Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Facilitating effects of valproate on reconsolidation of fear extinction
KCT0009483Phase 2Not yet recruiting
- Sponsor
- Seoul National University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of valproic acid in anxiety disorder, sponsored by Seoul National University. Planned start May 2024; status: not yet recruiting.
02
Drugs
valproic acid
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on KCT0009483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009483.